Rice University student startup challenge names winning teams

winner, winner

Six Rice University student-led startups pitched and were awarded $75,000 in equity-free funding. Photo courtesy of Rice

Rice University's six student startup teams competed for thousands of dollars in investment prizes, and one company came out on top — but a few other companies walked away with fresh funding too.

The 2022 H. Albert Napier Rice Launch Challenge doled out $75,000 to student-founded companies at Rice last week. Helix Earth Technologies, which has developed a filter that helps limit water waste in power plants, and its founder, Rawand Rasheed, a doctoral candidate in mechanical engineering at Rice University, won first place ans $35,000. The company been testing its technology on the power plants on campus.

The second-place team was EpiFresh, which created a protein-based coating doubles the shelf-life of fruit and vegetables, won $25,000. Guildata, which provides global health organizations with data that shows the greatest return on investment, won third place and $10,000.

The competition also included three additional awards:

  • Guildata won the $1,000 RISE@Rice: The Sen Social Pioneer Prize
  • SkySpace won the $1,500 Frank Liu Jr. Prize for Creative Innovations
  • Aqualight Materials won the $2,500 Chevron Tech Ventures Climate Innovations Prize
  • Berman Foods, an artisanal plant-based cheese and spread provider, won the $1,500 Norman E. Leebron Audience Choice Award

This year's competition saw participation from almost 200 students and a record 84 teams. The Liu Idea Lab for Innovation and Entrepreneurship whittled those entries down for judges, which included Thomas Ball, co-founder and managing director at Next Coast Ventures; Lisa Besserman, managing director at Expa; and Xiaodi Zhang, chief product officer at 1stDibs. On April 20, six finalists pitched in the championship round in five-minute pitches followed by seven minutes of questions.

Additionally, all competitors received personalized mentoring from experienced entrepreneurs, investors, and subject matter experts. The program started in 2017 with 15 student-run companies vying for a win. This year's NRLC was sponsored by Mercury Fund, T-Minus Solutions, and Chevron Technology Ventures.

These six finalists of The H. Albert Napier Rice Launch Challenge Championship will pitch on April 20. Photo courtesy of Rice University

Rice University startup pitch competition names 6 finalists

pitch perfect

Six student-founded startups are headed to the finals of a Rice University pitch competition — and this round is where the money is on the line.

The H. Albert Napier Rice Launch Challenge, open to undergraduate or graduate students in the spring as well as alumni in the summer, started in 2017 with 15 student-run companies vying for a win. The 2022 edition saw participation from almost 200 students and a record 84 teams. The Liu Idea Lab for Innovation and Entrepreneurship whittled those entries down and, after the first round of judging on March 24, six teams are headed the the finals.

The startups will make their pitches in-person at Rice University on Wednesday, April 20, starting at 5:30 pm and compete for over $75,000 in equity free funding.

These are the six student-led startups that will pitch at the finals are:

AutoEdge

AutoEdge is an artificial intelligence-powered quality assurance platform that assists small and medium manufacturers to quickly detect defects and provide clear actionable items to fix inefficiencies.

Founders:

  • Alfredo Costilla Reyes, Post-Doc – Computer Science, 2023, The DATA Lab led by Professor Ben Hu
  • Kwei-Herng Lai, M.S. – Computer Science
  • Daochen Zha, M.S. – Computer Science

Berman Foods

Berman Foods is a artisanal plant-based cheese and spread creator that uses nutritious ingredients.

Founder: Delaney Berman, MBA, 2022

​EpiFresh 

Another food-focused startup, ​EpiFresh is emphasizing fresher ingredients and less waste. Their healthy and sustainable protein-based coating doubles the shelf-life of fruit and vegetables, reducing waste by delaying decay as it moves from the farm to your fridge.

Founders:

  • Neethu Pottackal, PhD – Materials & Nanoengineering, 2024, Professor Pulickel Ajayan’s Lab
  • Aasha Zinke, Materials & Nano Engineering, 2024

​GradGenius

GradGenius is designed to provide users — those looking for a higher education opportunity — a one-stop-shop experience to selecting schools based on personal interests.

Founders:

  • David Akpakwu, MBA, 2023
  • Chinedum Peter Ezeakacha, MBA, 2023

Guildata

Guildata provides global health organizations with data that shows the greatest return on investment, by reduction in morbidity and mortality, for public health interventions in a non-disease centric approach.

Founders:

  • Stephanie Pons, MBA, 2022
  • Kurt Reece, MBA, 2022
  • Ryan Jensen, MBA, 2022

Helix Earth Technologies

Helix Earth Technologies is helping save our planet by helping power plant operators reduce their plant water use and subsequently reducing their overall operating costs.

Founder: Rawand Rasheed, PhD – Mechanical Engineering, 2023, Professor Daniel Preston’s Lab

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

New UH survey reveals concerns over AI data center growth in Houston

data findings

A new report out of the University of Houston shows that area residents remain wary of the long-term effects of operating data centers.

The recent survey from the University of Houston’s latest SPACE City Panel, conducted by the Center for Public Policy at the Hobby School of Public Affairs, shows that while 85 percent of Houston-area residents use AI, nearly 63 percent oppose the construction of AI data centers within 1 mile of their homes.

Respondents’ concerns centered around data centers’ high energy demand and the area’s power grid reliability. According to the survey, 32 percent of residents who oppose local data center projects would be more likely to support the centers if they relied on renewable energy over fossil fuels.

“Respondents understand that AI can bring economic and educational benefits, but they are also concerned about the physical infrastructure needed to fuel AI, especially data centers,” Soran Mohtadi, post-doctoral fellow at the Hobby School and a researcher on the report, said in a news release. “This physical infrastructure demands more electricity and water, leading to environmental impacts.”

Experts estimate that 6.5 gigawatts of data center capacity will be added to the Texas grid by 2030. And Houston’s data center capacity is predicted to more than double by 2028.

The Electric Reliability Council of Texas also projects electricity demand could reach 218 gigawatts by 2031, which would be more than double the record peak set in August 2023. Data centers are expected to account for 86 gigawatts of that new demand.

Survey respondents also said they are concerned about the state's future water supply, given the large amounts of water that data centers need to stay cool.

In terms of who’s responsible for that issue, 57.6 percent of respondents said they put the onus on Texas lawmakers, while 31.5 percent say tech companies should be responsible.

Additionally, more than 75 percent of respondents believed that data center developers and technology companies—not residents—should bear the cost of infrastructure upgrades to support data centers.

“Every decision legislators make has implications on residents’ everyday lives and local infrastructure now and in the future,” Maria P. Perez Arguelles, lead researcher on the report and research assistant professor at the Hobby School, added in the news release. “This issue is going to become more important in years to come, so this is just the beginning.”

Read the full report here.

Houston-born Cemvita makes breakthrough in sustainable fuel production

clean fuels

Houston-based biotech company Cemvita announced that it recently reached a critical milestone in the development of its FermOil product, which can be used to create Sustainable Aviation Fuel (SAF) and other renewable fuels at industrial scale.

The company shared in a news release that it completed a 75,000-liter industrial fermentation run at Belgium's Bio Base Europe Pilot Plant.

The campaign achieved target technical metrics for the production of FermOil, Cemvita’s renewable natural oil (RNO). FermOil is produced from industrial crude glycerin, an industrial byproduct, as opposed to traditional sugar-based feedstocks used in many bio-oil fermentation processes. It's designed to be a drop-in feedstock for creating SAFs.

Cemvita had previously advanced its FermOil production process through multiple scale-up stages before successfully reaching the 75,000-liter demonstration campaign, according to the company.

“This is not just a fermentation milestone,” Moji Karimi, CEO at Cemvita, said in the release. “It is a blueprint for how existing industrial infrastructure can evolve into circular bioeconomy infrastructure. Every biodiesel plant generating crude glycerin is a potential platform for renewable natural oil production.”

The milestone also supports the deployment of Cemvita’s industrial biomanufacturing platform, FermWorks, which integrates with existing energy and industrial infrastructure to turn waste carbon streams into SAFs and other materials. According to the release, Cemvita plans to move forward with commercial deployment discussions with partners in Brazil, Europe and in the UK. Cemvita already has a partnership with the Brazilian sustainable research institution REMA.

“We are proud to support innovative companies like Cemvita in scaling breakthrough industrial biotechnology solutions,” Hendrik Waegeman, head of business operations at Bio Base Europe Pilot Plant, added in the release. “Successfully operating at the 75,000-liter scale using a feedstock such as crude glycerin highlights both the maturity of the technology and the quality of the scale-up execution achieved by the Cemvita team.”

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Eli Lilly scoops up Houston biotech startup in $300 million deal

big pharma deal

Pharmaceutical giant Eli Lilly has acquired Houston biotech startup CrossBridge Bio, which develops antibody-drug conjugates for cancer, in a deal worth up to $300 million. The deal was celebrated by TMC Venture Fund and the University of Texas Health Science Center at Houston last week.

CrossBridge, founded in 2023, is developing ADCs based on research by Kyoji Tsuchikama and Zhiqiang An, both of UT Health Houston. Tsuchikama is an associate professor of medicinal chemistry and a globally recognized ADC pioneer, and An is a professor of molecular science and vice president of drug discovery.

Antibody-drug conjugates (ADCs) are a potent combination of targeted therapy and chemotherapy that kills cancer cells while saving healthy tissue.

Clinical trials for CrossBridge’s primary ADC candidate, CBB-120, are expected to start this year, pending approval from the U.S. Food and Drug Administration (FDA).

“I’m proud of how well our team has executed and advanced our platform in such a short time since the company’s founding,” Michael Torres, co-founder and CEO of CrossBridge, said in a news release. “By becoming a part of Lilly, a leader in patient-focused therapeutic development, we are well-positioned to further accelerate the clinical potential of this approach.”

Under the Lilly deal, CrossBridge shareholders were expected to receive an upfront payment along with a follow-up payment based on the achievement of certain milestones.

In 2024, CrossBridge closed a $10 million seed round. Among the investors in CrossBridge are the Texas Medical Center Venture Fund, CE-Ventures, Alexandria Venture Investments, Portal Innovations, Linden Lake Labs, and the Cancer Prevention and Research Institute of Texas (CPRIT). It was formed in TMC Innovation’s Accelerator for Cancer Therapeutics program."Built within the TMC ecosystem, CrossBridge Bio grew with the support, funding, and resources that helped shape its trajectory. TMC led the company's early financing and watched it evolve from its earliest days to its acquisition by Eli Lilly," William McKeon, president and CEO of the Texas Medical Center, shared in a LinkedIn post. "[This is a] strong reminder that breakthrough science and the right early backing can change what’s possible."
View All Listings